Section Arrow
NTRA.NASDAQ
- Natera
  suspend
Quotes are at least 15-min delayed:2026/04/28 23:07 EDT
Regular Hours
Last
 200.17
-4.22 (-2.06%)
Day High 
202.99 
Prev. Close
204.39 
1-M High
220 
Volume 
1.66M 
Bid
199.8
Ask
201.2
Day Low
195.97 
Open
200.96 
1-M Low
181.48 
Market Cap 
29.18B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 205.66 
20-SMA 203.87 
50-SMA 202.82 
52-W High 256.36 
52-W Low 131.8106 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.52/-0.55
Enterprise Value
29.30B
Balance Sheet
Book Value Per Share
11.99
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
2.31B
Operating Revenue Per Share
6.52
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QGENQiagen NV34.02-4.07-10.69%18.65PE
QUCYMainz Biomed N.V.0.5018-0.038-7.04%-- 
DHRDanaher Corp178.98-1.64-0.91%35PE
NEONeoGenomics9.02+0.41+4.76%-- 
BIAFbioAffinity Technologies Inc2.66+0.45+20.36%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.